John Stuart Patton serves as Executive at NEKTAR THERAPEUTICS, where they oversee executive responsibilities. Since joining the company, John Stuart Patton has executed 412 insider transactions totaling $5.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 15, 2006 involved selling 1,633 shares valued at $33.0K.
John Stuart Patton currently holds 254,876 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Stuart Patton has been a net seller of NKTR stock. They have purchased $0 and sold $5.9M worth of shares.
John Stuart Patton's most recent insider trade was on May 15, 2006, when they sold 1,633 shares at $20.21 per share.
Get notified when new Form 4 filings are submitted
| $2.80 |
| Discretionary |
| Mar 7, 2006 | NKTR | $76.4K | Sale | 3,859 | $19.80 | Discretionary |
| Mar 3, 2006 | NKTR | $0 | Award | 10,333 | $N/A | Discretionary |
| Jan 27, 2006 | NKTR | $440.0K | Sale | 20,000 | $22.00 | Discretionary |
| Jan 19, 2006 | NKTR | $452.4K | Option Exercise | 23,355 | $19.37 | Discretionary |
| Jan 18, 2006 | NKTR | $321.6K | Option Exercise | 16,645 | $19.32 | Discretionary |
| Jan 18, 2006 | NKTR | $347.8K | Option Exercise | 18,000 | $19.32 | Discretionary |
| Jan 13, 2006 | NKTR | $32.1K | Sale | 1,600 | $20.08 | Discretionary |
| Jan 13, 2006 | NKTR | $168.6K | Sale | 8,400 | $20.07 | Discretionary |
| Jan 13, 2006 | NKTR | $200.0K | Sale | 10,000 | $20.00 | Discretionary |
| Dec 14, 2005 | NKTR | $0 | Gift | 3,900 | $N/A | Discretionary |